Abstract
The adapter protein β-arrestin2 inhibits Mrgprb2 and FcεRI-mediated mast cell degranulation to attenuate pseudo-allergy and anaphylaxis. Thus, targeting β-arrestin2 in mast cells could provide novel therapeutic options for modulating pseudo-allergy and anaphylaxis.
Publication types
-
Letter
-
Research Support, N.I.H., Extramural
MeSH terms
-
Anaphylaxis / chemically induced
-
Anaphylaxis / immunology*
-
Anaphylaxis / pathology
-
Animals
-
Ciprofloxacin / adverse effects*
-
Ciprofloxacin / pharmacology
-
Drug Hypersensitivity / immunology*
-
Drug Hypersensitivity / pathology
-
Gene Expression Regulation / drug effects
-
Gene Expression Regulation / immunology
-
Immunoglobulin E / immunology*
-
Mast Cells / immunology*
-
Mast Cells / pathology
-
Mice
-
Mice, Knockout
-
beta-Arrestin 2 / immunology*
Substances
-
Arrb2 protein, mouse
-
beta-Arrestin 2
-
Immunoglobulin E
-
Ciprofloxacin